Aslan Pharmaceuticals Ltd (NASDAQ:ASLN)
| 2.02 Delayed Data As of Feb 21 |  -0.08 / -3.81%Today’s Change | 0.35 Today|||52-Week Range 8.18 | -0.49% Year-to-Date |
Latest ASLN News | Press Releases
No recent news for Aslan Pharmaceuticals Ltd.
Today’s Trading
| Previous close | 2.10 |
| Today’s open | 2.08 |
| Day’s range | 2.02 - 2.13 |
| Volume | 200,164 |
| Average volume (3 months) | 1,161,224 |
| Market cap | $65.7M |
Data as of 4:00pm ET, 02/21/2020
Growth & Valuation
| Earnings growth (last year) | +11.81% |
| Earnings growth (this year) | +52.62% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 2.16 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SNGXSoligenix Inc | -0.18 | -5.39% |
| LPTXLeap Therapeutics In... | -0.11 | -4.06% |
| ETTXEntasis Therapeutics... | -0.17 | -3.13% |
| ALPNAlpine Immune Scienc... | +0.13 | +4.18% |
Data as of 4:00pm ET, 02/21/2020
Financials
| Next reporting date | March 20, 2020 |
| EPS forecast (this quarter) | -$0.16 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$42.1M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Singapore, Central Singapore |
Forecasts
